Mechanism of intracellular regulation of protein kinase CK2: role of stimulus-mediated subnuclear association.
In our studies of protein kinase CK2, or casein kinase 2, we have focused on its regulation in relation to altered genomic activity in response to androgen action (through the function of the androgen receptor) in the male accessory sex gland, the prostate. We have documented that androgens exert a profound effect on CK2 in the prostate. Investigation of androgenic regulation of the molecular expression of prostatic CK2 suggested that CK2 gene transcription, although substantial in the prereplicative phase of cell proliferation, is not an early event in androgen action. The lack of rapid transcriptional regulation of CK2 by androgens suggested an alternative mechanism for our original observations on the early regulation of CK2-mediated reactions. A rigorous analysis of the CK2 in different compartments of the prostatic cell has suggested its differential regulation. For example, androgen withdrawal results in a rapid loss of CK2 protein and activity in the prostatic cell nucleus, whereas the activity and protein in the cytosol undergoes a slow decline over several days. A single dose of 5 alpha-dihydrotestosterone (5 alpha-DHT) given to 6-d castrated animals results in an increase in nuclear enzymatic activity as well as immunoreactive CK2 protein within 1 h, while a concomitant decrease is apparent in the cytosolic fraction. Within the nucleus, there appears to be a differential androgenic regulation of CK2 such that the enzyme associated with chromatin and nuclear matrix (NM) demonstrates a substantially greater androgen sensitivity than the enzyme in the nucleoplasm.(ABSTRACT TRUNCATED AT 250 WORDS)
Ahmed
K
K
Cellular and Molecular Biochemistry Research Laboratory, Department of Veterans Affairs Medical Center, Minneapolis, MN.
Tawfic
S
S
D000595:Amino Acid Sequence; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D047390:Casein Kinase II; D002467:Cell Nucleus / Q000201:enzymology; D002843:Chromatin / Q000201:enzymology; D003600:Cytosol / Q000201:enzymology; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D013196:Dihydrotestosterone / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D008297:Male; D008954:Models, Biological; D008969:Molecular Sequence Data; D015530:Nuclear Matrix / Q000201:enzymology*; D009919:Orchiectomy; D010455:Peptides / Q000138:chemical synthesis / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011467:Prostate / Q000187:drug effects* / Q000201:enzymology; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011944:Receptors, Androgen / Q000187:drug effects / Q000502:physiology; D014158:Transcription, Genetic / Q000187:drug effects
D002843:Chromatin; D010455:Peptides; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases; D004250:DNA Topoisomerases, Type II